Kidney patients needed for drug processing study
NCT ID NCT07426380
First seen Feb 28, 2026 · Last updated May 16, 2026 · Updated 15 times
Summary
This study looks at how the drug eloralintide moves through the body in people with severe kidney disease or kidney failure compared to healthy people. About 28 adults will get a single shot under the skin and be monitored for about 14 weeks. The goal is to understand dosing and safety, not to treat the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Floridian Clinical Research, LLC
RECRUITINGMiami Lakes, Florida, 33016-1518, United States
Contact Phone: •••-•••-••••
Contact
-
Omega Research Orlando LLC
RECRUITINGOrlando, Florida, 32808, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.